None listed
Conditions
Brief summary
The Warning study is a three-stage, mixed methods study, investigating the impact of selected warning labels. The first stage of the study involved focus groups, and was followed by stage two which included an online survey. Three labels were selected to be used in the third stage, the randomized controlled trial. The study was approved by an ethics committee on the 29th March 2022. The aim of the third stage of the study is to investigate the impact of three selected warning labels versus a 'no label' control condition, on consumers' intent to purchase and drink alcoholic beverages. It is hypothesized, that participants viewing alcoholic beverages with the test warning labels will be less likely to want to purchase and drink the alcoholic beverage. compared with those in the no-label control, irrespective of ethnicity or baseline AUDIT-C score.
Interventions
This trial is the third stage of a mixed-method study (Stage 1: focus groups (July 2022) ; Stage 2: online cross-sectional survey (June 2023); Stage 3: four-arm parallel group, randomized controlled trial (April/May 2024) undertaken online). For the trial, participants are recruited through a third-party market research company (Dynata and partners) and are screened and invited by email to take a web-based survey hosted by Dynata, which should take no longer than 10 minutes. Three different warning labels have been developed based on findings from Stages 1 and 2, stakeholder feedback and published research. These labels relate to liver cancer, violence, and heart attack/stroke, and utilise both a pictogram/image with text. After screening, eligible participants will be asked to provide baseline data via the online platform. Participants will then be randomly allocated (1:1:1:1 ratio) within the Dynata platform to view an image of an alcoholic drink (based on their response to a ‘drink of choice’ question (i.e. Beer, Wine, Spirits or ready-to-drink alcohol beverage [RTD]), with one of the three test warning labels, or no warning label (control) shown on the product, as described below. Arm 1: Alcohol Warning Label 1 - (Liver Cancer) Arm 2: Alcohol Warning Label 2 - (Violence) Arm 3: Alcohol Warning Label 3 - (Heart/Stroke) Arm 4: No label, control Participants will then answer a series of questions about the images they view. The warning labels will be shown on the alcoholic drink as well as beside the product. All products will display the mandatory pregnancy warning label and the standard drinks label. Participants will have the choice to view the text of the test warning labels in English only, or both English and Te Reo Maori. The images of the alcoholic drinks are fictitious brands. Dynata uses screening tools (QualityScore) to captures key data and tests behavioral elements as well as passive elements (mouse movement, speed, copy and pasting) to assign a quality score before respondents touch a survey. Scores below 20 are removed from the panel immediately.
Sponsors
Study design
Eligibility
Inclusion criteria
Participants will be: - Adults (18 years and over); - Report purchasing and consuming alcohol from an off-license retailer (e.g. supermarket, bottle store, uber eats, etc, but excluding drinking at a bar, pub, or restaurant) in the past week; - Only people who have drunk beer, wine, spirits or RTDs in the last week will be eligible. -Able to read English - Have access to the internet - Reside in New Zealand - Have not previously completed a Dynata survey about alcohol
Exclusion criteria
- Under 18 years of age - No access to the internet - Cannot read English - Have previously completed a survey about alcohol with Dynata - Not currently residing in New Zealand - Did not purchase and drink alcohol (beer, or wine, or spirits, or RTDs) in the past week.